The 2008 test · real data
Would XBI survive 2008?
Spdr S&P Biotech ETF
It doesn't have to be a hypothetical — XBI was there. Here's exactly what happened to it through the global financial crisis and the recovery that followed.
XBI fell 34% from its 2008-07 peak to its 2009-04 trough — $10,000 at the peak dipped to about $6,565 — and took 33 months from peak to full recovery (dividends reinvested).
Real 2007-01 – 2013-12 data. Past performance doesn't predict future results.
Growth of $10,000 in XBI · 2007-01 – 2013-12 · dividends reinvested
Would your portfolio survive it?
Replay 2008 — and the dot-com crash, COVID, and the 2022 rate shock — against any mix of supported U.S.-listed tickers, free.
Educational use only — not investment advice. Results are hypothetical.Read full disclaimer
This tool is for educational and informational purposes only and does not provide financial, investment, tax, legal, or accounting advice. Results are hypothetical and based on historical data and assumptions that may be inaccurate. Past performance does not guarantee future results. Consult a licensed professional before making investment decisions.